We work for a healthier world where the burden of disease is lightened through accessible, affordable, tailored therapies.
We discover and deliver selectively designed drug innovations that enhance the treatment experience. It all starts with the patient.
Moving beyond traditional therapies, we aim to improve adherence journeys for patients whose needs have been overlooked.
Latest News
Scienture Holdings, Inc. Announces Pricing of $3.9 Million Registered Direct Offering of Common Stock
SCIENTURE announces the shipment of launch quantities of Arbli™ (losartan potassium Oral Suspension) to its 3PL/Distribution Center and receipt of first wholesaler order, marking major commercialization milestones.
Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding
Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements
Scienture Holdings Announces Cancelation of ELOC
SCIENTURE Announces Executive Leadership Transition
See all
We invest in Delivering Better™
We are focused on identification and thoughtful selection of key access, commercialization, and support partners.
